Labetalol Hcl In Dextrose Injection
Product Images NDC 0143-9366

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Labetalol Hcl In Dextrose (NDC 0143-9366). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Labetalol HCl In Sodium Chloride Injection And Lab 1)

An instructional diagram of a syringe assembly for intravenous injection, labeled with parts including the syringe tip cap (marked to be removed), external collar (indicated not to remove), and plunger rod. The image is related to Labetalol Hydrochloride injection preparation and administration.*

FDA Label Image

Labetalol HCl In Sodium Chloride Injection And Lab 10

Label for Labetalol Hydrochloride Injection, 1 mg/mL (200 mg per 200 mL) in 5% Dextrose. It is a sterile, nonpyrogenic intravenous injection solution in a single-dose flexible container. Manufactured by HIKMA FARMACÊUTICA (Portugal) and distributed by Hikma Pharmaceuticals USA Inc. The label includes storage instructions, composition details, and usage warnings.*

FDA Label Image

Labetalol HCl In Sodium Chloride Injection And Lab 11

Label for Labetalol Hydrochloride in 5% Dextrose Injection, 200 mg per 200 mL (1 mg/mL) intravenous infusion. The sterile, nonpyrogenic, single-dose flexible container is ready to use. Distributed by Hikma Pharmaceuticals USA Inc. with storage instructions and usage warnings included.*

FDA Label Image

Labetalol HCl In Sodium Chloride Injection And Lab 12

The image shows part of the packaging label for Labetalol HCl in Sodium Chloride injection, including an expiration date of 12/2099, a lot number 1812000.1, and a quantity of 0000. A QR code is also visible in the upper right corner of the label.*

FDA Label Image

Bag 9363 (Labetalol HCl In Sodium Chloride Injection And Lab 2)

An instructional line drawing showing two hands demonstrating how to remove a protective cap from a vial or injection device, with an arrow indicating a twisting motion.*

FDA Label Image

Bag 9364 (Labetalol HCl In Sodium Chloride Injection And Lab 3)

Chemical structure of labetalol hydrochloride, showing the molecular arrangement of atoms including benzene rings, hydroxyl groups, and the hydrochloride component as indicated.*

FDA Label Image

Bag 9365 (Labetalol HCl In Sodium Chloride Injection And Lab 4)

Label for Labetalol Hydrochloride injection in 0.72% Sodium Chloride, 100 mg per 100 mL (1 mg/mL) strength. The sterile, nonpyrogenic, single-dose flexible container is for intravenous infusion and ready to use. Manufactured by Hikma Pharmaceuticals USA Inc. Instructions include storage at room temperature and precautions about discarding unused portions and container integrity.*

FDA Label Image

Bag 9366 (Labetalol HCl In Sodium Chloride Injection And Lab 5)

Label for Labetalol Hydrochloride in 0.72% Sodium Chloride Injection, 1 mg/mL (100 mg per 100 mL) intravenous injection. The product is sterile, nonpyrogenic, and supplied in a single-dose flexible container, ready for intravenous infusion. Manufactured by Hikma Farmacêutica (Portugal) and distributed by Hikma Pharmaceuticals USA Inc.*

FDA Label Image

Bag Serizliation Image (Labetalol HCl In Sodium Chloride Injection And Lab 6)

Label for Labetalol Hydrochloride injection in 0.72% Sodium Chloride, with a concentration of 1 mg/mL (200 mg per 200 mL). It is for intravenous infusion, sterile and nonpyrogenic, supplied in a single-dose flexible container ready to use. Manufactured by Hikma Farmacêutica (Portugal) and distributed by Hikma Pharmaceuticals USA Inc.*

FDA Label Image

Labetalol HCl In Sodium Chloride Injection And Lab 7

Labetalol Hydrochloride 1 mg/mL Injection in 0.72% Sodium Chloride, 200 mg per 200 mL (intravenous infusion) single-dose flexible container. Label includes administration instructions, storage conditions, and manufacturing information by Hikma Farmacêutica and distribution by Hikma Pharmaceuticals USA Inc. The product is sterile, nonpyrogenic, preservative-free, and ready to use.*

FDA Label Image

Labetalol HCl In Sodium Chloride Injection And Lab 8

Labetalol Hydrochloride in 0.72% Sodium Chloride Injection 300 mg per 300 mL (1 mg/mL) is shown on this label. It is an intravenous injection for intravenous infusion, ready to use, sterile, nonpyrogenic, and preservative-free. The single-dose flexible container is manufactured by Hikma Farmacêutica (Portugal) and distributed by Hikma Pharmaceuticals USA Inc.*

FDA Label Image

Labetalol HCl In Sodium Chloride Injection And Lab 9

Label for Labetalol Hydrochloride in 0.72% Sodium Chloride Injection, 300 mg per 300 mL (1 mg/mL) intravenous injection. The label states it is a sterile, nonpyrogenic, single-dose flexible container ready for intravenous infusion. Manufactured by Hikma Farmacêutica (Portugal) and distributed by Hikma Pharmaceuticals USA Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.